DEVELOPMENT AND CHARACTERIZATION OF AZITHROMYCIN-LOADED TRANSDERMAL PATCHES FOR ENHANCED ANTIBACTERIAL EFFICACY.

Transdermal drug delivery systems provide a convenient and patient-friendly alternative to oral or injectable formulations by administering medication continuously through the skin. To address antibiotic resistance and poor oral compliance, a transdermal patch for azithromycin, a broad-spectrum macrolide antibiotic, could improve therapeutic outcomes¹⁻³. Patches that circumvent first-pass metabolism and maintain steady plasma levels can reduce adverse effects, enhance patient compliance, and even prevent resistance development. This study describes the design, formulation, and evaluation of azithromycin-loaded transdermal patches. We selected matrix and drug-in-adhesive designs to control release and enhance skin penetration of this big chromophore molecule. Several excipients were optimized, including skin penetration enhancers (such as ethanol and surfactants), sticky polymers for comfort and consistent release, and stabilizers to keep the medicine intact during storage⁴⁻⁷. The manufacturing techniques investigated included solvent casting for cost-effectiveness, hot-melt extrusion for uniformity, and new 3D-printing options for precise dosage control. Patch thickness, weight uniformity, drug content, mechanical strength, and surface shape were all examined during physicochemical characterization. In vitro permeation investigations employing Franz diffusion cells revealed the appropriate medication flux over synthetic membranes and human skin equivalents. Cytotoxicity assays and skin irritation tests were used to assess safety, which were required before in vivo pharmacokinetic (PK) studies in animal models⁸⁻¹². Transdermal delivery achieved therapeutic plasma levels comparable to single oral dosages, with less peak-to-trough variability, according to PK investigations. Stability studies demonstrated that physical qualities, chemical potency, and microbiological integrity remained intact throughout lengthy storage. In the future, individualized "smart" patches with sensors and configurable release profiles could transform antibiotic therapy by allowing for real-time monitoring and dosage recommendations¹³⁻¹⁶. However, additional clinical trials and regulatory confirmation are required. In conclusion, azithromycin transdermal patches hold great promise for improving antibacterial therapy by increasing compliance, assuring consistent administration, and minimizing resistance. Continued improvement in formulation, manufacturing, and clinical evaluation could make these patches viable alternatives to traditional antibiotic regimens¹⁷⁻¹⁹.